Skip to main content

Table 1 Anthropometric and biochemical measures in four PCOS phenotypes (mean ± SD and median in brackets)

From: Insulin resistance and high molecular weight adiponectin in obese and non-obese patients with Polycystic Ovarian Syndrome (PCOS)

Variable

PCOS phenotype 1

PCOS phenotype 2

PCOS phenotype 3

PCOS phenotype 4

P-value*

Weight (Kg)

64.3 ± 13.4 (62.0)

63.0 ± 9.9 (63.0)

61.0 ± 4.1 (61.0)

70.0 ± 13.6 (68.5)

0.23

Height (cm)

160.3 ± 6.5 (160.5)

160.3 ± 5.0 (160.0)

159.2 ± 3.3 (159.0)

159.2 ± 5.9 (158.5)

0.87

BMI (Kg/m2)

24.7 ± 4.5 (23.8)

24.7 ± 5.0 (23.0)

24.1 ± 1.6 (24.5)

27.6 ± 5.6 (26.5)

0.11

Waist Circumference (cm)

86.8 ± 14.0 (85.0)

82.8 ± 9.3 (83.0)

84.6 ± 10.3 (80.0)

94.1 ± 13.9 (94.5)

0.04

Hip Circumference (cm)

101.7 ± 10.9 (100.5)

94.6 ± 10.6 (97.0)

95.4 ± 6.6 (96.0)

103.7 ± 12.5 (103.0)

0.05

Fasting glucose (mg/dl)

89.7 ± 9.7 (88.5)

92.1 ± 6.1 (90.0)

92.4 ± 4.3 (94.0)

92.2 ± 6.3 (92.5)

0.13

Total cholesterol (mg/dl)

170.6 ± 50.6 (170.0)

167.9 ± 40.5 (173.0)

181.4 ± 18.6 (187.0)

170.0 ± 28.6 (169.0)

0.69

HDL-cholesterol (mg/dl)

44.7 ± 9.5 (46.0)

43.8 ± 9.0 (44.0)

47.2 ± 5.6 (47.0)

41.7 ± 9.7 (41.5)

0.53

LDL-cholesterol (mg/dl)

72.2 ± 33.3 (71.0)

68.5 ± 18.4 (68.0)

73.0 ± 23.2 (72.0)

69.0 ± 18.5 (70.0)

0.97

Triglycerides (mg/dl)

113.6 ± 65.2 (99.0)

126.5 ± 72.9 (96.0)

100.2 ± 28.2 (92.0)

133.4 ± 70.8 (127.0)

0.54

Insulin level (μIU/mL)

7.8 ± 3.2 (7.7)

8.7 ± 4.1 (7.5)

10.7 ± 6.5 (7.5)

16.6 ± 4.1 (16.5)

< 0.001

HOMA-IR

1.7 ± 0.8 (1.7)

2.0 ± 0.9 (1.8)

2.4 ± 1.5 (1.7)

3.8 ± 1.0 (3.8)

< 0.001

TSH (ng/dl)

3.0 ± 1.7 (2.7)

2.8 ± 1.8 (2.5)

3.2 ± 2.3 (3.2)

3.8 ± 2.5 (3.2)

0.53

Prolactin (ng/ml)

11.6 ± 10.1 (8.4)

6.3 ± 3.2 (5.3)

6.8 ± 4.1 (5.0)

9.5 ± 8.4 (7.1)

0.34

LH (mIU/ml)

4.8 ± 4.0 (4.0)

5.7 ± 3.6 (5.0)

4.9 ± 1.8 (4.9)

6.7 ± 5.6 (4.6)

0.30

FSH (mIU/ml)

6.4 ± 2.2 (6.6)

6.5 ± 2.6 (5.8)

9.2 ± 3.8 (9.0)

6.5 ± 2.1 (6.3)

0.10

17(OH) progesterone (ng/ml)

1.3 ± 0.9 (1.0)

1.3 ± 0.7 (1.1)

1.3 ± 0.7 (1.1)

2.4 ± 3.3 (1.5)

0.12

Total Testosterone (nmol/l)

0.5 ± 0.2 (0.4)

0.5 ± 0.2 (0.4)

0.4 ± 0.3 (0.4)

0.7 ± 0.2 (0.7)

0.009

Free Androgen Index

1.4 ± 0.9 (1.3)

1.2 ± 0.5 (1.1)

0.7 ± 0.6 (0.5)

2.7 ± 2.2 (2.1)

0.001

DHEAS (μmol/l)

2.9 ± 1.5 (3.0)

2.8 ± 1.8 (3.0)

2.7 ± 1.2 (2.5)

3.9 ± 2.0 (3.8)

0.12

SHBG (nmol/l)

54.5 ± 57.2 (35.0)

44.5 ± 20.0 (41.0)

71.0 ± 43.8 (63.0)

36.7 ± 23.0 (30.0)

0.07

HMWA (ng/ml)

2986.3 ± 1824.4 (2476.5)

2628.5 ± 1098.9 (2390.0)

2359.4 ± 1365.7 (1816.0)

2798.0 ± 1813.7 (2372.0)

0.88

  1. HDL High-Density Lipoprotein, LDL Low-Density Lipoprotein, HOMA-IR Homeostatic Model Assessment – Insulin Resistance, TSH Thyroid Stimulating Hormone, LH Luteinizing Hormone, FSH Follicle Stimulating Hormone, DHEAS DeHydroEpiandrosterone Sulfate, SHBG Sex Hormone Binding Globulin, HMWA High Molecular Weight Adiponectin. Free Androgen Index: (Testosterone /SHBG)*100
  2. * Difference between mean level, analyzed by ANOVA for normally distributed variables and kruskal-Wallis test for variables without normal distribution